4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-061366
Chief Financial Officer sold 19,191 shares at an average $3.07 ($58,849)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-28 | Sale : show line 1 in the form 10b5-1 | −1,709 | $3.17 | $5,418 | 372,858 | D |
| 2025-04-28 | Sale : show line 2 in the form 10b5-1 | −981 | $3.17 | $3,110 | 371,877 | D |
| 2025-04-29 | Sale : show line 3 in the form 10b5-1 | −3,558 | $3.23 | $11,492 | 368,319 | D |
| 2025-04-30 | Sale : show line 4 in the form 10b5-1 | −12,943 | $3.00 | $38,829 | 355,376 | D |
| Open-market sales · 19,191 sh · avg $3.07 · $58,849 | ||||||
Loading xslF345X05/ownership.xml…